Emerging antiangiogenic therapies for non-small-cell lung cancer
Author:
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
http://www.tandfonline.com/doi/pdf/10.1586/era.11.146
Reference119 articles.
1. Cancer Statistics, 2009
2. American Cancer Society. Cancer Facts & Figures, 2008. American Cancer Society, Inc., Atlanta, GA, USA (2008).
3. Phase III Trial of Two Versus Four Additional Cycles in Patients Who Are Nonprogressive After Two Cycles of Platinum-Based Chemotherapy in Non–Small-Cell Lung Cancer
4. Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
5. Duration of Chemotherapy in Advanced Non–Small-Cell Lung Cancer: A Randomized Trial of Three Versus Six Courses of Mitomycin, Vinblastine, and Cisplatin
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Advances in Lung Cancer Treatment Using Nanomedicines;ACS Omega;2022-12-29
2. Efficacy and safety of brigatinib in ALK-positive non-small cell lung cancer treatment: A systematic review and meta-analysis;Frontiers in Oncology;2022-11-03
3. Effectiveness of anlotinib in patients with small‐cell lung cancer and pleural effusion: Subgroup analysis from a randomized, multicenter, phase II study;Thoracic Cancer;2021-10
4. Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer;European Journal of Pharmacology;2020-12
5. Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer;Journal of Drug Delivery Science and Technology;2020-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3